SCHEMBL17714728

SCHEMBL17714728

c1ccc(-c2ccc(-c3cc(-c4cccc(-c5ccc6c7ccccc7n(-c7ccc(-c8cccc9c8c8ccccc8n9-c8ccccc8)cc7)c6c5)c4)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.38
▸ KMT2A Q03164 6/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ MAPT P10636 6/20 0.38
▸ HPGD P15428 6/20 0.38
▸ KDM4E B2RXH2 5/20 0.38
▸ LMNA P02545 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ NTSR1 P30989 1/20 0.36
▸ MAPK1 P28482 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ MAOB P27338 3/20 0.33
▸ MAOA P21397 2/20 0.33
▸ AVPR1A P37288 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16171476 0.98 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17714788 0.98 KDM4E (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17714738 0.98 KDM4E (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17714892 0.98 KDM4E (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17714823 0.98 KDM4E (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17714746 0.97 KDM4E (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17714745 0.96 KDM4E (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17714958 0.95 MEN1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17714915 0.95 KDM4E (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17714760 0.94 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11111231-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-09-07 — — US disclosed
EP-3015465-B1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEMICAL LTD (KR) 2019-09-04 — — EP disclosed
US-20190127352-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2019-05-02 — — US disclosed
US-10253016-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2019-04-09 — — US disclosed
US-20160204359-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2016-07-14 — — US disclosed
US-20160204359-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2016-07-14 — — US disclosed
EP-3015465-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG Chem, Ltd. (KR) 2016-05-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10253016-B2 Heterocyclic compound and organic light-emitting device comprising same CRY1, CRY2, NR2E3 MEN1 799/4885KMT2A 396/4885ALDH1A1 157/4885
US-20160204359-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CRY2, NR2E3 MEN1 799/4885KMT2A 396/4885ALDH1A1 157/4885
US-11111231-B2 Heterocyclic compound and organic light-emitting device comprising same CRY1, CRY2, NR2E3 MEN1 799/4885KMT2A 396/4885ALDH1A1 157/4885
US-20190127352-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CRY2, NR2E3 MEN1 799/4885KMT2A 396/4885ALDH1A1 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback